False-positive HIV serology, Candida lusitaniae pneumonia, and a novel mutation in the CYBB gene

• Published in: Immunobiology (1979) 2021-07, Vol.226 (4), p.152110-152110, Article 152110
• Main Authors: Banday, Aaqib Zaffar, Nataraj, Lokesh, Jindal, Ankur Kumar, Kaur, Harsimran, Gummadi, Anjani, Sharma, Madhubala, Pandiarajan, Vignesh, Rawat, Amit
• Format: Article
• Language: English
• Subjects: C. lusitaniae; Candida; Candidiasis - blood; Candidiasis - genetics; Chronic granulomatous disease; Clavispora; CYBB; DNA, Viral - genetics; False Positive Reactions; Granulomatous Disease, Chronic - blood; Granulomatous Disease, Chronic - genetics; HIV; HIV - genetics; HIV - immunology; HIV Infections - blood; HIV Infections - diagnosis; Humans; Infant; Male; Mutation; NADPH Oxidase 2 - genetics; Novel mutation; Pneumonia - blood; Pneumonia - genetics; Positive serology; Saccharomycetales; Viral Proteins - immunology
• ISSN: 0171-2985; 1878-3279
• DOI: 10.1016/j.imbio.2021.152110

Chronic granulomatous disease (CGD) presents with a myriad of clinical manifestations pertaining to both immunodeficiency and hyperinflammation. Although Candida infection is a signature organism for patients with CGD, C. lusitaniae pneumonia in CGD has rarely been reported. C. lusitaniae is a ubiquitous ascomycete predominantly infecting immunocompromised hosts and has the potential to rapidly develop multi-drug resistance during therapy. Additionally, C. lusitaniae is recognized for its variable resistance against amphotericin B. To date, C. lusitaniae infections in patients with CGD have not been reviewed in detail. False-positive HIV serology, resulting from polyclonal hypergammaglobulinemia, has been reported in association with several infections, auto-immune diseases, and malignancies. Although CGD is often associated with hypergammaglobulinemia, a false-positive HIV serology in CGD has not been reported previously. We report a combination of unique findings in a child with CGD – a false-positive HIV serology, Candida lusitaniae pneumonia, and a novel CYBB mutation. We also provide a detailed review of C. lusitaniae infections in patients with CGD. In patients with CGD, C. lusitaniae has been reported to cause lymphadenitis (cervical, abdominal), fungemia, meningoencephalitis, or abscesses in the liver and spleen. Many CGD patients with C. lusitaniae infection have associated inflammatory complications of the gut (inflammatory bowel disease, colitis). Additionally, almost all C. lusitaniae infections in CGD have been reported in young infants or in patients receiving long-term immunosuppressive therapy. This reflects that further immunocompromise (in addition to the underlying immune deficiency in CGD) may specifically predispose to C. lusitaniae infection (unlike other candidal infections). Most of the CGD patients with documented C. lusitaniae infection have X-linked form of the disease which generally has been postulated to have a more severe clinical phenotype than the autosomal recessive forms of the disease. HIV serology may be positive in patients with CGD and other inborn errors of immunity as a result of hypergammaglobulinemia. C. lusitaniae, which may have peculiar and evolving antimicrobial sensitivity patterns, needs to be considered in patients with CGD and pneumonia. Lastly, to reiterate, CGD should to be considered in patients with proven C. lusitaniae infection.